Exclusive Ca19-9 Monoclonal Antibody Take An Extra 75% Off [w0gtR6u4]

Exclusive Ca19-9 Monoclonal Antibody Take An Extra 75% Off [w0gtR6u4]: Your Ultimate Diagnostic Tool

Introducing the Exclusive Ca19-9 Monoclonal Antibody Take An Extra 75% Off [w0gtR6u4], a cutting-edge diagnostic tool designed for accurate detection of CA19-9, a key biomarker associated with various cancers. This antibody is a game-changer in the field of oncology, offering a reliable and efficient method for identifying cancerous cells. With its exceptional sensitivity and specificity, the Exclusive Ca19-9 Monoclonal Antibody Take An Extra 75% Off [w0gtR6u4] is an invaluable asset for healthcare professionals seeking precise and timely diagnoses.

Product Details and Specifications

The Exclusive Ca19-9 Monoclonal Antibody Take An Extra 75% Off [w0gtR6u4] is produced using high-quality mouse cells, ensuring purity and consistency. This antibody exhibits strong reactivity against human CA19-9, making it ideal for various diagnostic applications. Its applications include Immunohistochemistry (IHC-P), providing a versatile tool for pathologists and researchers. The Exclusive Ca19-9 Monoclonal Antibody Take An Extra 75% Off [w0gtR6u4] is also known as CA19-9 and is primarily localized in the cytoplasm, particularly in the pancreas, which makes it highly specific for pancreatic adenocarcinomas. Here are some of the key features and specifications of this product:

• Host: Mouse
• Reactivity: Human
• Applications: IHC-P
• Synonyms: CA19-9
• Cellular Localization: Cytoplasm
• Tissue Specificity: Pancreas
• Storage: -20°C, protected from light, valid for 12 months
• Shipping: Ice bag

Practical Applications and Benefits

The Exclusive Ca19-9 Monoclonal Antibody Take An Extra 75% Off [w0gtR6u4] is not just a laboratory tool; it has practical applications that can significantly impact patient care. By enabling accurate and early detection of CA19-9, this antibody can help healthcare providers identify cancerous conditions such as pancreatic, gastric, breast, colon, and gallbladder cancers. This early detection can lead to timely treatment and improved patient outcomes. Whether you are a researcher or a practicing healthcare professional, the Exclusive Ca19-9 Monoclonal Antibody Take An Extra 75% Off [w0gtR6u4] offers numerous benefits:

• Enhanced Diagnostics: Accurate and reliable detection of CA19-9 for various types of cancer.
• Improved Patient Care: Early detection of cancer can lead to more effective treatment and better patient survival rates.
• Research Advancement: A valuable tool for researchers in the field of oncology, enabling them to study cancer biomarkers and develop new therapies.